Hepatitis C

Results: 3748



#Item
1Acute Hepatitis C in the PROUD pilot study Juan Tiraboschi, Liz Brodnicki, Brady Michael, John Saunders, Schembri Gabriel, Mark Roche, Julie Fox on behalf of the PROUD study

Acute Hepatitis C in the PROUD pilot study Juan Tiraboschi, Liz Brodnicki, Brady Michael, John Saunders, Schembri Gabriel, Mark Roche, Julie Fox on behalf of the PROUD study

Add to Reading List

Source URL: www.proud.mrc.ac.uk

Language: English - Date: 2017-07-17 12:33:31
    2PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

    PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

    Add to Reading List

    Source URL: www.abbvie.ca

    Language: English - Date: 2018-07-18 19:08:19
      3PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes   

      PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes   

      Add to Reading List

      Source URL: www.abbvie.ca

      Language: English - Date: 2018-07-18 04:02:55
        4Contact PD/PI: Braithwaite, Ronald Scott A. SPECIFIC AIMS Many persons with HIV have Hepatitis C (HCV) co-infection and consume alcohol.1,2 Now that highly effective and easily tolerated therapies for HCV are available,

        Contact PD/PI: Braithwaite, Ronald Scott A. SPECIFIC AIMS Many persons with HIV have Hepatitis C (HCV) co-infection and consume alcohol.1,2 Now that highly effective and easily tolerated therapies for HCV are available,

        Add to Reading List

        Source URL: medicine.yale.edu

        Language: English - Date: 2017-10-26 03:35:18
          5PRESS RELEASE AbbVie’s TECHNIVIE™ Receives Health Canada Approval for Genotype 4 Chronic Hepatitis C Infection  TECHNIVIE provides an opportunity to treat adults who have genotype 4 (GT4) chronic hepatitis C

          PRESS RELEASE AbbVie’s TECHNIVIE™ Receives Health Canada Approval for Genotype 4 Chronic Hepatitis C Infection  TECHNIVIE provides an opportunity to treat adults who have genotype 4 (GT4) chronic hepatitis C

          Add to Reading List

          Source URL: www.abbvie.ca

          Language: English - Date: 2018-07-18 12:42:01
            6

            Membership Form Membership Criteria: We are a non-profit, Canadian organization. Our Organization is committed to improving outcomes for those affected by Hepatitis B and/or Hepatitis C

            Add to Reading List

            Source URL: www.actionhepatitiscanada.ca

            Language: English - Date: 2016-10-04 21:20:17
              7PRESS RELEASE Health Canada Grants Priority Review to AbbVie’s Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)  

              PRESS RELEASE Health Canada Grants Priority Review to AbbVie’s Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)  

              Add to Reading List

              Source URL: www.abbvie.ca

              Language: English - Date: 2018-07-18 07:06:17
                8PRESS RELEASE British Columbia Joins Other Provinces to Reimburse AbbVie’s HOLKIRATM PAK  HOLKIRA PAK now reimbursed in British Columbia for patients with genotype 1 hepatitis C virus infection

                PRESS RELEASE British Columbia Joins Other Provinces to Reimburse AbbVie’s HOLKIRATM PAK  HOLKIRA PAK now reimbursed in British Columbia for patients with genotype 1 hepatitis C virus infection

                Add to Reading List

                Source URL: www.abbvie.ca

                Language: English - Date: 2018-07-18 09:22:13
                  9PRESS RELEASE AbbVie’s HOLKIRATM PAK Now Reimbursed in all Four Atlantic Provinces  HOLKIRA PAK now reimbursed in Nova Scotia, New Brunswick and Newfoundland and Labrador for patients with genotype 1 hepatitis C vir

                  PRESS RELEASE AbbVie’s HOLKIRATM PAK Now Reimbursed in all Four Atlantic Provinces  HOLKIRA PAK now reimbursed in Nova Scotia, New Brunswick and Newfoundland and Labrador for patients with genotype 1 hepatitis C vir

                  Add to Reading List

                  Source URL: www.abbvie.ca

                  Language: English - Date: 2018-07-18 07:08:17
                    10Injection drug use and comprehensive HIV and Hepatitis C prevention in rural US communities Moderator: Jeremiah Johnson, Treatment Action Group Dr. Carrie Ann Lawrence, Assistant Researcher, Indiana School of Public Heal

                    Injection drug use and comprehensive HIV and Hepatitis C prevention in rural US communities Moderator: Jeremiah Johnson, Treatment Action Group Dr. Carrie Ann Lawrence, Assistant Researcher, Indiana School of Public Heal

                    Add to Reading List

                    Source URL: www.preventionjustice.org

                    - Date: 2017-03-21 12:41:42